These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9509069

  • 1. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [Abstract] [Full Text] [Related]

  • 2. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
    Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
    [Abstract] [Full Text] [Related]

  • 4. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P.
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ, Fig LM, Barkan AL, Shapiro B.
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [Abstract] [Full Text] [Related]

  • 6. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
    Kotzmann H, Bernecker P, Hübsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A.
    J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
    [Abstract] [Full Text] [Related]

  • 8. Bone metabolism and body composition in Japanese patients with active acromegaly.
    Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H, Chihara K.
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and circulating cytokines in patients with acromegaly.
    Longobardi S, Di Somma C, Di Rella F, Angelillo N, Ferone D, Colao A, Merola B, Lombardi G.
    J Endocrinol Invest; 1998 Nov; 21(10):688-93. PubMed ID: 9854685
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B.
    J Bone Miner Metab; 2006 Nov; 24(1):72-8. PubMed ID: 16369902
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB, Erbaş T.
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
    [Abstract] [Full Text] [Related]

  • 12. Trabecular bone score as a skeletal fragility index in acromegaly patients.
    Hong AR, Kim JH, Kim SW, Kim SY, Shin CS.
    Osteoporos Int; 2016 Mar; 27(3):1123-1129. PubMed ID: 26446771
    [Abstract] [Full Text] [Related]

  • 13. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR, Farias ML.
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [Abstract] [Full Text] [Related]

  • 14. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
    Fassbender WJ, Balli M, Görtz B, Hinrichs B, Kaiser HE, Tracke HS.
    In Vivo; 2000 Dec; 14(5):611-8. PubMed ID: 11125545
    [Abstract] [Full Text] [Related]

  • 15. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A, Gedik O.
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [Abstract] [Full Text] [Related]

  • 16. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
    Välimäki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E.
    Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
    [Abstract] [Full Text] [Related]

  • 17. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J.
    Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
    [Abstract] [Full Text] [Related]

  • 18. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [Abstract] [Full Text] [Related]

  • 19. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly.
    Jockenhövel F, Rohrbach S, Deggerich S, Reinwein D, Reiners C.
    Eur J Med Res; 1996 May 24; 1(8):377-82. PubMed ID: 9360937
    [Abstract] [Full Text] [Related]

  • 20. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G.
    Clin Endocrinol (Oxf); 2000 Mar 24; 52(3):319-27. PubMed ID: 10718830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.